Pfizer pressing against 0.618 arc. Potential breakout toward $27.95

Pfizer, Inc. (PFE): Arc cycle analysis

Overview: Based on Arc Cycle Analysis applied to the 1D chart, Pfizer is interacting with the 0.618 Resistance Arc within the current Arc Cycle. Price is testing this Resistance Arc, suggesting the potential for a breakout toward the next Resistance Arc.

Metric	Reading
Market bias	Bullish
Preferred scenario	Potential Breakout / Advance Toward the Next Resistance Arc
Primary target zone	27.95
Scenario invalidation	Sustained close below $26.10
Current arc level	Resistance Arc (0.618)
Cycle status	Testing Resistance Arc
Arc integrity	Weakening

Market outlook

Price is testing the 0.618 Resistance Arc, where continued buying pressure could result in a breakout toward the next Resistance Arc. A sustained breakout above the Resistance Arc would support continued movement toward the next Resistance Arc (0.786 Arc).

Conversely, failure to achieve a sustained 1D close above the Resistance Arc would invalidate the bullish scenario and could shift the outlook toward the next Support Arc (0.5 Arc).